HFB-100204
HFB-100204 is a human monoclonal antibody (mAb) targeting CXCR5. HFB-100204 reduces CXCR5+ immune cells, including B cells and Tfh cells, in the blood and spleen of hCXCR5 knockout mice. HFB-100204 can be used in autoimmune diseases research[1].
Product Specifications
UNSPSC
12352203
Target
CXCR
Related Pathways
GPCR/G Protein; Immunology/Inflammation
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Smiles
[HFB-100204]
References & Citations
[1]Ducos G M, et al. CXCR5 as a Therapeutic Target in Autoimmune Diseases: Insights from Sjögren’s Syndrome[J]. Journal of Human Immunity, 2025, 1 (CIS2025) : CIS2025abstract. 30.
Shipping Conditions
Room temperature
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items